BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li JZ, Blankson JN. How elite controllers and posttreatment controllers inform our search for an HIV-1 cure. J Clin Invest 2021;131:149414. [PMID: 34060478 DOI: 10.1172/JCI149414] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Trémeaux P, Lemoine F, Mélard A, Gousset M, Boufassa F, Orr S, Monceaux V, Gascuel O, Lambotte O, Hocqueloux L, Saez-Cirion A, Rouzioux C, Avettand-Fenoel V. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control. Microbiol Spectr 2023;11:e0326722. [PMID: 36692300 DOI: 10.1128/spectrum.03267-22] [Reference Citation Analysis]
2 Louten J. Human Immunodeficiency Virus. Essential Human Virology 2023. [DOI: 10.1016/b978-0-323-90565-7.00011-3] [Reference Citation Analysis]
3 Khetan P, Liu Y, Dhummakupt A, Persaud D. Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays. Viruses 2022;14. [PMID: 36560612 DOI: 10.3390/v14122608] [Reference Citation Analysis]
4 Brombin C, Bagaglio S, Cugnata F, Castagna A, Uberti-Foppa C, Salpietro S, Di Serio C, Morsica G. Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models. Sci Rep 2022;12:18575. [PMID: 36329104 DOI: 10.1038/s41598-022-23289-4] [Reference Citation Analysis]
5 Madrid-elena N, Serrano-villar S, Gutiérrez C, Sastre B, Morín M, Luna L, Martín L, Santoyo-lópez J, López-huertas MR, Moreno E, García-bermejo ML, Moreno-pelayo MÁ, Moreno S. Selective miRNA inhibition in CD8+ cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses. Front Immunol 2022;13:998368. [DOI: 10.3389/fimmu.2022.998368] [Reference Citation Analysis]
6 Wallace Z, Singh PK, Dorrell L. Combination strategies to durably suppress HIV-1: Soluble T cell receptors. Journal of Virus Eradication 2022;8:100082. [DOI: 10.1016/j.jve.2022.100082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Rutishauser RL, Trautmann L. CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies. Curr Opin HIV AIDS 2022;17:315-24. [PMID: 35777930 DOI: 10.1097/COH.0000000000000748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mensching L, Hoelzemer A. NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses. Front Immunol 2022;13:883728. [PMID: 35711433 DOI: 10.3389/fimmu.2022.883728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Moran JA, Turner SR, Marsden MD. Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches. Front Immunol 2022;13:905773. [PMID: 35693831 DOI: 10.3389/fimmu.2022.905773] [Reference Citation Analysis]
10 Ahmed RA, Adekoya KO, Onwuamah CK, Oboh BO, Iyer SS, Oluwatosin AS, Audu RA, Ezechi OC. Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa. Viruses 2022;14:1270. [PMID: 35746741 DOI: 10.3390/v14061270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kreider EF, Bar KJ. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies. Curr HIV/AIDS Rep 2022;19:194-206. [PMID: 35404007 DOI: 10.1007/s11904-022-00604-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Cummins NW, Badley AD. Could proteasome inhibition improve therapeutic vaccine response in HIV? Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.05.008] [Reference Citation Analysis]
13 Balasubramaniam M, Thapa S, Davids B, Bryer A, Xu C, Shi J, Aiken C, Pandhare J, Perilla JR, Dash C. HIV-1 Mutants that Escape the Cytotoxic T-Lymphocytes are Defective in Viral DNA Integration.. [DOI: 10.1101/2021.08.29.458043] [Reference Citation Analysis]